Evaluation of Sedation in COVID-19 ARDS

Goethe University

Status: Completed

Conditions: Prone Position; Pulmonary Ventilation; Severe Acute Respiratory Syndrome Coronavirus 2; Hypnotics and Sedatives

Treatments: Other: Treatment group

Study type: Observational

Funder types: Other

Identifiers

NCT04667936

#20-643 -Sed II

Details and patient eligibility

About

This study focuses on the evaluation of various factors repeatedly discussed in relation to the impaired sedation of intubated ventilated COVID-19 patients. The sedation response of >100 moderately to severely affected COVID-19 ARDS was evaluated. The sedation level was measured at the bedside using the Richmond Agitation and Sedation Scale and ventilator synchrony. The evaluation was performed according to the static evaluation plan with respect to age, storage therapy and organ failure.

Enrollment: 114 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

moderate to severe COVID-19 ARDS

Exclusion criteria

None

Trial design

114 participants in 1 patient group

moderate to severe COVID-19 ARDS

Description:

patients with an oxygenation index \<200 under intubation anesthesia and mechanical ventilation.

Treatment:

Other: Treatment group